Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF CASH FLOWS

v3.21.1
STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Cash Flows from Operating Activities:                      
Net (loss) income     $ 6,725,368     $ (321,102) $ 4,595,625 $ (2,398,841) $ 5,094,479 $ (17,665,187) $ 4,098,520
Adjustments to reconcile net (loss) income to net cash used in operating activities:                      
Gain on marketable securities, dividends and interest held in Trust Account     (1,128,747)     (1,114,579) (1,760,594) (1,201,382) (3,322,448) (1,261,249) (4,554,158)
Loss (gain) on revaluation of warrant liability $ 1,106,250 $ 6,936,250 (5,763,750) $ 951,250 $ (3,617,500) 1,172,500 (3,617,500) 2,278,750 (2,666,250) 16,533,750 (520,000)
Changes in operating assets and liabilities:                      
Prepaid expenses     16,903     (20,595)   15,654 (101,988) 51,905 (62,738)
Accounts payable     11,337     (60,517) (138,629) 284,630 79,620 830,344 83,995
Accrued expenses     41,140     16,140 82,575 405,711 (87,694) 770,551 6,166
Net cash used in operating activities     (97,749)     (328,153) (836,317) (615,478) (1,002,075) (739,886) (948,215)
Cash Flows from Investing Activities:                      
Cash deposited in Trust Account             (287,500,000)   (287,500,000)   (287,500,000)
Net cash used in investing activities             (287,500,000)   (287,500,000)   (287,500,000)
Cash Flows from Financing Activities:                      
Proceeds from note payable to related party             250,000   250,000   250,000
Repayment of note payable and advances from related party             (252,206)   (252,206)   (250,000)
Proceeds received from initial public offering             287,500,000   287,500,000   287,500,000
Proceeds from private placement             7,750,000   7,750,000   7,750,000
Offering costs paid             (5,151,990)   (5,151,990)   (5,236,990)
Net cash provided by financing activities             290,095,804   290,095,804 0 290,013,010
Net change in cash     (97,749)     (328,153) 1,759,487 (615,478) 1,593,729 (739,886) 1,564,795
Cash - beginning of period 1,261,642 1,492,046 1,589,795 1,784,487   1,589,795 25,000 1,589,795 25,000 1,589,795 25,000
Cash - end of period $ 974,317 $ 1,261,642 $ 1,492,046 $ 1,618,729 $ 1,784,487 $ 1,261,642 1,784,487 $ 974,317 1,618,729 $ 849,909 1,589,795
Supplemental disclosure of noncash activities:                      
Offering costs included in accounts payable             2,600   2,600   2,600
Remeasurement of ordinary shares subject to possible redemption             26,789,590   26,789,590   26,789,590
Deferred underwriting commissions             $ 9,187,500   $ 9,187,500   $ 9,187,500